Semi-Annual Statement Of Income

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7576262

Concept 2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
Semi-annual statement of income
Statement of income
Net sales
55,573,000,000 JPY
JPY
55,573,000,000 JPY
53,753,000,000 JPY
1,820,000,000 JPY
57,708,000,000 JPY
57,708,000,000 JPY
55,906,000,000 JPY
1,802,000,000 JPY
JPY
Cost of sales
25,010,000,000 JPY
25,689,000,000 JPY
Gross profit (loss)
30,562,000,000 JPY
32,019,000,000 JPY
Ordinary profit (loss)
12,976,000,000 JPY
14,322,000,000 JPY
Selling, general and administrative expenses
18,168,000,000 JPY
18,129,000,000 JPY
Extraordinary income
4,000,000 JPY
195,000,000 JPY
Extraordinary losses
338,000,000 JPY
60,000,000 JPY
Selling, general and administrative expenses
Salaries
4,211,000,000 JPY
4,287,000,000 JPY
Profit (loss) before income taxes
12,641,000,000 JPY
14,457,000,000 JPY
Operating profit (loss)
12,394,000,000 JPY
JPY
12,394,000,000 JPY
11,433,000,000 JPY
960,000,000 JPY
13,889,000,000 JPY
13,889,000,000 JPY
12,891,000,000 JPY
998,000,000 JPY
JPY
Non-operating income
600,000,000 JPY
477,000,000 JPY
Non-operating income
Interest income
5,000,000 JPY
5,000,000 JPY
Dividend income
428,000,000 JPY
387,000,000 JPY
Income taxes
3,492,000,000 JPY
4,211,000,000 JPY
Non-operating expenses
18,000,000 JPY
44,000,000 JPY
Profit (loss)
9,149,000,000 JPY
10,246,000,000 JPY
Non-operating expenses
Interest expenses
12,000,000 JPY
12,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
2,000,000 JPY
195,000,000 JPY
Extraordinary losses
Impairment losses
304,000,000 JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.